JP drafts for public comments, March 1 - 31, 2016
New monographs
- Calcium Levofolinate Hydrate (001-1603eng.pdf)
- Pazufloxacin Mesilate (002-1603eng.pdf)
- Pentobarbital Calcium Tablets (003-1603eng.pdf)
- Zonisamide (004-1603eng.pdf)
Ultraviolet-visible reference spectra
- Calcium Levofolinate Hydrate (005-1603eng.pdf)
- Pazufloxacin Mesilate (006-1603eng.pdf)
- Zonisamide (007-1603eng.pdf)
Infrared reference spectra
- Calcium Levofolinate Hydrate (008-1603eng.pdf)
- Pazufloxacin Mesilate (009-1603eng.pdf)
- Zonisamide (010-1603eng.pdf)
To send the comment on these drafts, the guidance is as follows:
- Download this form in Word format
- Fill in the form
- Prepare and attach the supportive data that scientifically validate the comment when appropriate
- Send it to the email address: JPdraft1603eng@pmda.go.jp
Related Information
Note: The information provided with the comment may be released to the public whenever necessary (except the individual name, organization, address, telephone & fax numbers and e-mail address or the attached supportive data).